114 related articles for article (PubMed ID: 30478638)
1. [Non-drug treatment of rheumatoid arthritis : An analysis of claims data and a survey of insured persons (Project PROCLAIR)].
Jacobs H; Callhoff J; Hoffmann F; Zink A; Albrecht K
Z Rheumatol; 2019 Mar; 78(2):119-126. PubMed ID: 30478638
[TBL] [Abstract][Full Text] [Related]
2. [Outpatient care and disease burden of rheumatoid arthritis : Results of a linkage of claims data and a survey of insured persons].
Albrecht K; Luque Ramos A; Callhoff J; Hoffmann F; Minden K; Zink A
Z Rheumatol; 2018 Mar; 77(2):102-112. PubMed ID: 28324149
[TBL] [Abstract][Full Text] [Related]
3. [Prescription frequency of physical therapy for inflammatory rheumatic diseases].
Albrecht K; Marschall U; Zink A; Callhoff J
Z Rheumatol; 2022 Jun; 81(5):360-368. PubMed ID: 35316384
[TBL] [Abstract][Full Text] [Related]
4. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
Zink A; Listing J; Ziemer S; Zeidler H;
J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
[TBL] [Abstract][Full Text] [Related]
5. [Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version].
Callhoff J; Albrecht K; Hoffmann F; Poddubnyy D; Günther KP; Zink A
Z Rheumatol; 2019 Oct; 78(8):713-721. PubMed ID: 31273459
[TBL] [Abstract][Full Text] [Related]
6. [Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data].
Neubauer S; Zeidler H; Linder R; Zeidler J
Dtsch Med Wochenschr; 2019 Jun; 144(12):e70-e79. PubMed ID: 30654405
[TBL] [Abstract][Full Text] [Related]
7. Use of Physical Therapy in Patients With Osteoarthritis in Germany: An Analysis of a Linkage of Claims and Survey Data.
Jacobs H; Callhoff J; Albrecht K; Postler A; Saam J; Lange T; Goronzy J; Günther KP; Hoffmann F
Arthritis Care Res (Hoboken); 2021 Jul; 73(7):1013-1022. PubMed ID: 32609432
[TBL] [Abstract][Full Text] [Related]
8. Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project.
Callhoff J; Albrecht K; Hoffmann F; Poddubnyy D; Günther KP; Zink A
Z Rheumatol; 2019 Dec; 78(Suppl 2):73-79. PubMed ID: 31342161
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].
Hense S; Luque Ramos A; Callhoff J; Albrecht K; Zink A; Hoffmann F
Z Rheumatol; 2016 Oct; 75(8):819-827. PubMed ID: 27120440
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of Rheumatoid Arthritis in Germany: Analysis of Longitudinal Data of Statutory Health Insurance].
Kienitz C; Grellmann C; Hapfelmeier J
Gesundheitswesen; 2021 May; 83(5):367-373. PubMed ID: 32858756
[TBL] [Abstract][Full Text] [Related]
11. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
Pope JE; Hong P; Koehler BE
J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
[TBL] [Abstract][Full Text] [Related]
12. Rheumatologic care of nursing home residents with rheumatoid arthritis: a comparison of the year before and after nursing home admission.
Luque Ramos A; Albrecht K; Zink A; Hoffmann F
Rheumatol Int; 2017 Dec; 37(12):2059-2064. PubMed ID: 28821941
[TBL] [Abstract][Full Text] [Related]
13. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
Westhoff G; Schneider M; Raspe H; Zeidler H; Runge C; Volmer T; Zink A
Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
[TBL] [Abstract][Full Text] [Related]
14. [Effects of therapy on functional ability of patients with rheumatoid arthritis].
Kapidzić-Basić N; Selesković H; Mulić S
Med Arh; 2007; 61(3):164-8. PubMed ID: 18232281
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.
Bonafede MM; Fox KM; Johnson BH; Watson C; Gandra SR
Clin Ther; 2012 Feb; 34(2):457-67. PubMed ID: 22284901
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities in Patients with Rheumatoid Arthritis and Their Association with Patient-reported Outcomes: Results of Claims Data Linked to Questionnaire Survey.
Luque Ramos A; Redeker I; Hoffmann F; Callhoff J; Zink A; Albrecht K
J Rheumatol; 2019 Jun; 46(6):564-571. PubMed ID: 30647170
[TBL] [Abstract][Full Text] [Related]
17. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
[TBL] [Abstract][Full Text] [Related]
18. The Association of Low Income with Functional Status and Disease Burden in German Patients with Rheumatoid Arthritis: Results of a Cross-sectional Questionnaire Survey Based on Claims Data.
Callhoff J; Luque Ramos A; Zink A; Hoffmann F; Albrecht K
J Rheumatol; 2017 Jun; 44(6):766-772. PubMed ID: 28412709
[TBL] [Abstract][Full Text] [Related]
19. The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis.
Zink A; Listing J; Niewerth M; Zeidler H;
Ann Rheum Dis; 2001 Mar; 60(3):207-13. PubMed ID: 11171679
[TBL] [Abstract][Full Text] [Related]
20. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
